Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene

Infection and Immunity

Volumn 67, Issue 8, 1999, Pages 3855-3863

  Rodrigues, Mauricio M ^a   Ribeirão, Marcelo ^a   Pereira Chioccola, Vera ^b   Renia, Laurent ^c   Costa, Fabio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^c INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DNA VACCINE;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; CATALYSIS; CELLULAR IMMUNITY; CHAGAS DISEASE; GENETIC CODE; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNIZATION; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; TRYPOMASTIGOTE;

EID: 0032783138     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.8.3855-3863.1999     Document Type: Article

References (52)

1. Abrahamsohn, I. A., and R. L. Coffman. 1995. Cytokine and nitric oxide regulation of immunosuppression in Trypanosoma cruzi infection. J. Immunol. 155:3955-3963.
2. Arnholdt, A. C. V., M. R. Pluvezam, D. M. Russo, A. P. C. Lima, R. C. Pedrosa, S. G. Reed, and J. Scharfstein. 1993. Analysis and partial epitope mapping of human T cell responses to Trypanosoma cruzi cysteinyl proteinase. J. Immunol. 151:3171-3179.
3. Bonato, V. L. D., V. M. F. Lima, R. E. Tascon, D. B. Lowrie, and C. L. Silva. 1998. Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosu-infected mice. Infect. Immun. 66:169-175.
4. Chow, Y.-H., B.-L. Chiang, Y.-L. Lee, W.-K. Chi, W.-C. Liu, Y.-T. Chen, and M.-H. Tao. 1998. Development of Th1 and Th2 Populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J. Immunol. 160:1320-1329.
5. Chu, R. S., O. S. Targoni, A. M. Krieg, P. V. Lehmann, and C. V. Harding. 1997. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186:1623-1631.
6. Costa, F., G. Franchin, V. L. Pereira-Chioccola, M. Ribeirão, S. Schenkman, and M. M. Rodrigues. 1998. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice. Vaccine 16:768-774.
7. Cross, G. A. M., and G. B. Tackle. 1993. The surface trans-sialidase family of Trypanosoma cruzi. Annu. Rev. Microbiol. 46:383-411.
8. Davis, H. L., R. Weerantsa, T. J. Waldschmidt, L. Tygrett, J. Schorr, and A. M. Krieg. 1998. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160:870-876.
9. de Andrade, A. L., F. Zicker, R. M. de Oliveira, S. Almeida Silva, A. Luquetti, L. R. Travassos, I. C. Almeida, S. S. de Andrade, J. G. de Andrade, and C. M. Martelli. 1996. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 348:1407-1413.
10. + T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect. Immun. 66:1527-1533.
11. Dos Reis, G. A. 1997. Cell-mediated immunity in experimental Trypanosoma cruzi infection. Parasitol. Today 13:335-342.
12. Falk, K., O. Rötzschke, K. Ores, J. Metzger, G. Jung, and H.-G. Rammensee. 1991. Identification of naturally processed viral nonapeptide allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast. J. Exp. Med. 174:425-434.
13. Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in acquired immune response. Science 272:50-53.
14. Feltquate, D. M., S. Heaney, R. G. Webster, and H. L. Robinson. 1997. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158:2278-2284.
15. Grunathan, S., D. L. Sacks, D. R. Brown, S. L. Reiner, H. Charest, N. Glaichenhaus, and R. A. Seder. 1997. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J. Exp. Med. 186:1137-1147.
16. Higuchi, M., T. de Brito, M. Reis, A. Barbosa, G. Belloti, A. Pereira-Barreto, and F. Pileggi. 1993. Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic Chagas' disease and chagasic myocarditis: light microscopy and immunohistochemical findings. Cardiovasc. Pathol. 2:101-104.
17. Hölscher, C., G. Kölher, U. Müller, H. Mossman, G. A. Schaub, and F. Brombacher. 1998. Defective nitric oxide effector function lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect. Immun. 66:1208-1215.
18. Huygen, K., J. Content, O. Denis, D. L. Montgomery, A. M. Yawman, R. R. Deck, C. M. Dewitt, I. M. Orme, S. Baldwin, C. D'Souza, A. Drowart, E. Lozes, P. Vandenbussche, J. P. van Vooren, M. A. Liu, and J. B. Ulmer. 1996. Immunogenicity and protective efficacy of tuberculosis DNA vaccine. Nat. Med. 2:893-898.
19. Jakob, T., P, S. Walker, A. M. Krieg, M. C. Udey, and J. C. Vogel. 1998. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161:3042-3049.
20. Klinman, D. M., A.-K. Yi, S. L. Beacauge, J, Conover, and A. M. Krieg. 1996. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin-6, interleukin-12, and interferon-γ. Proc. Nat. Acad. Sci. USA 93:2879-2883.
21. Klinman, D. M., G. Yamshchikov, and Y. Ishigaatsubo. 1997. Contribution of CpG motif to the immunogenicity of DNA vaccines. J. Immunol. 158: 3635-3639.
22. Leclerc, C., E. Deriaud, M. Rojas, and R. G. Whalen. 1997. The preferential induction of a Th1 immune response by DNA-based immunization is mediated by immunostimulatory effect of plasmid DNA. Cell. Immunol. 179:97-106.
23. Li, X., S. Sambhara, C. X. Li, M. Ewasyshyn, M. Parrington, J. Caterini, O. James, G. Cates, R.-P. Du, and M. Klein. 1998. Protection against respiratory syncitial virus infection by DNA immunization. J. Exp. Med. 158:681-688.
24. Matzinger, P. 1991. The JAM test. A simple assay for DNA degradation and cell death. J. Immunol. Methods 15:185-192.
25. Mor, G., D. M. Klinman, S. Shapiro, E. Hagiwara, M. Sedegah, J. A. Norman, S. L. Hoffman, and A. D. Steinberg. 1995. Complexity of the cytokine and antibody response elicited by immunization mice with Plasmodium yoelii circumsporoite protein plasmid DNA. J. Immunol. 155:2039-2046.
26. Munoz-Fernandez, M. A., M. A. Fernandez, and M. Fresno. 1992. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur. J. Immunol. 22:301-307.
27. + T-cell clones: T helper type 1-like phenotype and reactivity with shed trypomastigote antigens. Infect. Immun. 61:3250-3258.
28. Raz, E., H. Tighe, M. Corr, J. A. Dudler, M. Roman, S. L. Swain, H. L. Spielgeberg, and D. A. Carson. 1996. Preferential induction of Th1 immune response and inhibition of specific IgE antibody formation by plasmid immunization. Proc. Natl. Acad. Sci. USA 93:5141-5145.
29. Reed, S. G. 1988. In vivo administration of IFN-γ induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infection. J. Immunol. 140:4342-4347.
30. 29a.Ribeirao, M. Unpublished observations.
31. Ribeirāo, M., V. L. Pereira-Chioccola, D. Eichinger, M. M. Rodrigues, and S. Schenkman. 1997. Temperature differences for trans-glycosylation and hydrolysis reaction reveal an acceptor binding site in the catalytic mechanism of Trypanosoma cruzi trans-sialidase. Glycobiology 7:1237-1246.
32. Rocha, A., A. C. de Menezes, A. M. da Silva, M. S. Ferreira, S. A. Nishioka, M. K. Burgarelli, E. Almeida, G. Turcato Jr., K. Metze, and E. R. Lopes. 1994. Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. Am. J. Trop. Med. Hyg. 50:261-268.
33. Rodrigues, M., R. S. Nussenzweig, P. Romero, and F. Zavala. 1992. In vivo cytotoxic activity of CD8+ T cell clones correlates with their level of expression of adhesion molecules. J. Exp. Med. 175:895-905.
34. Rodrigues, M. M., A. S. Cordey, G. Arreaza, P. Romero, G. Corradin, J. L. Maryanski, R. Nussenzweig, and F. Zavala. 1991. Cytotoxic T cell clones derived against the circumsporozoite protein of Plasmodium yoelii protects against malaria. Int. Immunol. 3:579-585.
35. 33a.Rodrigues, M. M., and V. L. Pereira-Chioccola. Unpublished observations.
36. Rottenberg, M. E., M. Bakhiet, T. Olsson, K. Kristensson, T. Mak, H. Wigzell, and A. Orn. 1993. Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infect. Immun. 61:5129-5133.
37. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
38. Sartori, A. M., M. A. Shikanai-Yasuda, V. A. Neto, and M. H. Lopes. 1998. Follow-up of 18 patients with human immunodeficiency virus infection and chronic Chagas' disease, with reactivation of Chagas' disease in three patients. Clin. Infect. Dis. 26:177-179.
39. Sato, Y., M. Roman, H. Tighe, D. Lee, M. Corr, M. Nguyen, G. J. Silverman, M. Lotz, D. A. Carson, and E. Raz. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273: 352-354.
40. Schenkman, S., J. Man-Shiow, G. W. Hart, and V. Nussenzweig. 1991. A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells. Cell 65:1117-1125.
41. Silva, J. S., G. N. R. Vespa, M. A. G. Cardoso, J. C. S. Aliberti, and F. Q. Cunha. 1995. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect. Immun. 63:4862-4867.
42. Silva, J. S, P. J. Morrissey, K. H. Grabstein, K. M. Mohler, D. Anderson, and S. G. Reed. 1992. Interleukin 10 and IFN-gamma regulation of experimental Trypanosoma cruzi infection. J. Exp. Med. 175:169-174.
43. Tarleton, R. L. 1995. The role of T cells in Trypanosoma cruzi infections. Parasitol. Today 11:7-12.
44. Tarleton, R. L., J. Sun, L. Zhang, M. Postan, and L. Glimcher. 1996. Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int. Immunol. 8:13-22.
45. Trinchieri, G. 1994. IL-12: a cytokine produced by antigen-presenting cells with immunoregulatory function in the generation of T-helper cell type 1 and cytotoxic lymphocytes. Blood 84:4008-4027.
46. Uemura, H., S. Schenkman, V. Nussenzweig, and D. Eichinger. 1992. Only some members of a gene family in Trypanosoma cruzi encode proteins that express both trans-sialidase and neuraminidase activities. EMBO J. 11:3837-3844.
47. Ulmer, J. B., J. C. Sadoff, and M. A. Liu. 1996. DNA vaccines. Curr. Opin. Immunol. 8:531-536.
48. + T cells against influenza virus induced by vaccination with nucleoprotein DNA. J. Virol. 72:5648-5653.
49. Viotti, R., C. Vigliano, H. Armenti, and E. Segura. 1994. Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow up. Am. Heart J. 127:151-162.
50. Wizel, B., M. Nunes, and R. Tarleton. 1997. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses. J. Immunol. 159:6120-6130.
51. Wizel, B., N. Garg, and R. Tarleton. 1998. Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection. Infect. Immun. 66:5073-5081.
52. Zhu, X., N. Venkaprasad, H. S. Thangaraj, M. Hill, M. Singh, J. Ivanyi, and H. M. Vordermeier. 1997. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J. Immunol. 158:5921-5926.